Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allient (ALNT) Receivables (2016 - 2025)

Allient (ALNT) has disclosed Receivables for 16 consecutive years, with $88.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables rose 12.7% to $88.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $88.8 million, a 12.7% increase, with the full-year FY2025 number at $88.8 million, up 12.7% from a year prior.
  • Receivables was $88.8 million for Q4 2025 at Allient, down from $91.7 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $91.7 million in Q3 2025 to a low of $51.2 million in Q4 2021.
  • A 5-year average of $77.3 million and a median of $82.5 million in 2024 define the central range for Receivables.
  • Peak YoY movement for Receivables: surged 48.74% in 2022, then fell 8.92% in 2024.
  • Allient's Receivables stood at $51.2 million in 2021, then soared by 48.74% to $76.2 million in 2022, then grew by 11.7% to $85.1 million in 2023, then dropped by 7.46% to $78.8 million in 2024, then grew by 12.7% to $88.8 million in 2025.
  • Per Business Quant, the three most recent readings for ALNT's Receivables are $88.8 million (Q4 2025), $91.7 million (Q3 2025), and $84.9 million (Q2 2025).